DURHAM, NORTH CAROLINA, UNITED STATES, May 31, 2023/EINPresswire.com/ — POLARISqb, an industry leader in accelerating drug discovery using quantum computing, is excited to announce Quantum-Aided Drug Design (QuADD). QuADD is a subscription-based SaaS platform that quickly identifies a library of top candidate molecules for drug targets. In order to find a new preclinical lead, the first step is to build a library of small molecules that may interact with the target protein binding pocket. Traditionally, library design involves wet lab testing that takes years, costs millions, and is limited to a narrow chemical space. With the power of quantum computing, QuADD is able to build highly diverse and customized libraries of optimized molecules in days.

Read more here.